US Stem Cell Responds to FDA’s Regenerative Medicine Guidelines – Business Wire (press release)
|
US Stem Cell Responds to FDA's Regenerative Medicine Guidelines
Business Wire (press release) SUNRISE, Fla.–(BUSINESS WIRE)–U.S. Stem Cell, Inc. (OTC: USRM), a leader in development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today responded to the recently-announced Food and Drug … Challenges of stem cell therapy for cancer | SunStar McGill hosts speakers on the ethical and legal ramifications of stem cell research Modified blood stem cells reverse type 1 diabetes in mice |
